当前位置: X-MOL首页全球导师 海外导师 › Penson, Peter

个人简介

Job title: Senior Lecturer in Pharmacology and Pharmacy Practice I am a pharmacist with an established research profile in cardiovascular health and disease. I have been Senior Lecturer in Pharmacology and Pharmacy Practice at Liverpool John Moores University since 2009. In 2016 I was appointed as Editor in Chief of 'Autonomic and Autacoid Pharmacology' My research interests include investigating clinical outcomes in cardiovascular disease, with a particular focus on hypertension, dyslipidaemias and ischaemia-reperfusion injury. I am primarily involved in meta-analysis and clinical trials. In this work I am lucky to work with many international experts in the Lipid and Blood Pressure Meta Analysis Collaboration http://lbpmcgroup.umed.pl . I employ a range of research methods in the laboratory in addition to my interest in meta analysis. I am the author of several research papers and textbook chapters. I have conducted research at Cardiff University (UK), University of Surrey (UK), and the University of Regensburg (Germany). I am registered as a pharmacist with the General Pharmaceutical Council (UK). I am a member of The British Pharmacological Society, The International Society for Heart Research, The British Society for Heart Failure, The British Society for Cardiovascular Research and the Royal Pharmaceutical Society. I am a Fellow of the Higher Education academy. Teaching Responsibilities I teach cardiovascular physiology, pharmacology and therapeutics on the MPharm. programme. As a pharmacist, I am also involved in teaching Pharmacy Practice elements of the course. I have responsibility for undergraduate and postgraduate masters projects in addition to supervising PhD candidates. Administrative Responsibilities: Module Group Leader: Scientific Basis of Therapeutics Module Leader: 'The Scientific Basis of Therapeutics 3' M.Pharm L6 (36 Credits) Module Development Leader: 'Complexities of Healthcare' M.Pharm L6 (120 Credits) Degrees 2009, Cardiff University, United Kingdom, Ph.D. 2004, University of Wales, United Kingdom, M.Pharm.

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Penson P, McGowan M, Banach M. 2017. Evaluating bempedoic acid for the treatment of hyperlipidaemia Expert Opinion on Investigational Drugs, >DOI Brie D, Sahebkar A, Penson P, Dinca M, Ursoniu S, Serban M-C, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GYH, Wong ND, Rysz J, Banach M. 2016. Effects of Pentoxifylline on Inflammatory Markers and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Journal of Hypertension, >DOI Kotani K, Serban M-C, Penson P, Lippi G, Banach M. 2016. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – some answers and still many questions Critical Reviews in Clinical Laboratory Sciences, :1-28 >DOI Brie D, Penson P, Serban M-C, Toth PP, Simonton C, Serruys PW, Banach M. 2016. Bioresorbable scaffold — A magic bullet for the treatment of coronary artery disease? International Journal of Cardiology, 215 :47-59 >DOI Dinca M, Serban M-C, Sahebkar A, Mikhailidis DP, Toth PP, Martin SS, Blaha MJ, Blüher M, Gurban C, Penson P, Michos ED, Hernandez AV, Jones SR, Banach M. 2016. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials Pharmacological Research, 107 :360-371 >DOI Penson P, McGowan M, Banach M. 2017. Evaluating bempedoic acid for the treatment of hyperlipidaemia Expert Opinion on Investigational Drugs, >DOI Penson P, Serban M-C, Ursoniu S, Banach M. 2017. DOES COFFEE CONSUMPTION ALTER PLASMA LIPOPROTEIN(A) CONCENTRATIONS? A SYSTEMATIC REVIEW. Critical Reviews in Food Science and Nutrition, >DOI Awad K, Penson P, Banach M. 2016. D-003 (Saccharum officinarum): The forgotten lipid-lowering agent Pharmacological Research, 114 :42-46 >DOI Brie D, Sahebkar A, Penson P, Dinca M, Ursoniu S, Serban M-C, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GYH, Wong ND, Rysz J, Banach M. 2016. Effects of Pentoxifylline on Inflammatory Markers and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Journal of Hypertension, >DOI Kotani K, Serban M-C, Penson P, Lippi G, Banach M. 2016. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – some answers and still many questions Critical Reviews in Clinical Laboratory Sciences, :1-28 >DOI Brie D, Penson P, Serban M-C, Toth PP, Simonton C, Serruys PW, Banach M. 2016. Bioresorbable scaffold — A magic bullet for the treatment of coronary artery disease? International Journal of Cardiology, 215 :47-59 >DOI Dinca M, Serban M-C, Sahebkar A, Mikhailidis DP, Toth PP, Martin SS, Blaha MJ, Blüher M, Gurban C, Penson P, Michos ED, Hernandez AV, Jones SR, Banach M. 2016. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials Pharmacological Research, 107 :360-371 >DOI Penson PE. 2012. Lecturing: A lost art Currents in Pharmacy Teaching and Learning, 4 :72-76 >DOI Broadley KJ, Davies RH, Escargueil C, Lee ATL, Penson P, Thomas EJ. 2011. SYNTHESIS OF ANTAGONISTS OF MUSCARINIC (M-3) RECEPTORS COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 76 :781-801 >DOI >Link Penson PE, Ford WR, Kidd EJ, Broadley KJ. 2008. Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn Schmiedebergs Arch Pharmacol, 378 :589-597 >DOI >Link Penson PE, Ford WR, Broadley KJ. 2007. Vasopressors for cardiopulmonary resuscitation. Does pharmacological evidence support clinical practice? Pharmacol Ther, 115 :37-55 >DOI >Link Broadley KJ, Penson PE. 2006. Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological properties. Eur J Pharmacol, 536 :279-286 >DOI >Link Broadley KJ, Penson PE. 2004. The roles of alpha- and beta-adrenoceptor stimulation in myocardial ischaemia. Auton Autacoid Pharmacol, 24 :87-93 >DOI >Link Penson PE. 2016. Autonomic & Autacoid Pharmacology 2016: The year in review. Auton Autacoid Pharmacol, 36 :27-27 >DOI >Link Penson P. 2016. Autonomic & Autacoid Pharmacology: past, present and future Autonomic and Autacoid Pharmacology, >DOI Penson PE. 2009. Incense - A problematic method of drug-delivery. Med Hypotheses, 72 :482 >DOI >Link Penson P. 2007. Peter Penson on one way to cut the NHS drugs budget The Health service journal, Penson PE. 2006. Wasted journey [15] Pharmaceutical Journal, 276 :322 Penson PE. 2005. Academic rigour? [9] Pharmaceutical Journal, 275 :752 Penson P. 2004. Apply liberally [12] Pharmaceutical Journal, 273 :644

推荐链接
down
wechat
bug